JAZZ Return on Tangible Equity | Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc (JAZZ) Return on Tangible Equity

2026-06-30: Return Tang Equity -91.55%.
2026-03-31: Return Tang Equity -2.00%.
2025-12-31: Return Tang Equity 18.36%.
2025-09-30: Return Tang Equity 15.14%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-91.55%
2026-03-31	-2.00%
2025-12-31	18.36%
2025-09-30	15.14%
2025-06-30	13.93%
2025-03-31	-20.94%
2024-12-31	-23.55%
2024-09-30	-16.67%
2024-06-30	-12.94%
2024-03-31	-10.09%
2023-12-31	-12.08%
2023-09-30	-2.20%
2023-06-30	2.21%
2023-03-31	3.76%
2022-12-31	5.09%
2022-09-30	0.42%
2022-06-30	1.13%
2022-03-31	9.36%
2021-12-31	6.78%
2021-09-30	3.19%
2021-06-30	-0.77%
2021-03-31	68.99%
2020-12-31	47.12%
2020-09-30	90.05%
2020-06-30	-213.72%
2020-03-31	-82.60%
2019-12-31	-472.83%
2019-09-30	-196.21%
2019-06-30	-134.30%
2019-03-31	-66.66%
2018-12-31	-58.86%
2018-09-30	-94.72%
2018-06-30	-56.80%
2018-03-31	-45.92%
2017-12-31	-45.81%
2017-09-30	-27.69%
2017-06-30	205.06%
2017-03-31	1374.65%
2016-12-31	-458.49%
2016-09-30	-149.28%
2016-06-30	-1530.65%
2016-03-31	-196.91%
2015-12-31	718.05%
2015-09-30	-208.88%
2015-06-30	-94.62%
2015-03-31	-52.95%
2014-12-31	-10.97%
2014-09-30	-4.66%
2014-06-30	-9.09%
2014-03-31	-7.97%
2013-12-31	323.14%
2013-09-30	4909.30%
2013-06-30	-609.16%
2013-03-31	-403.69%
2012-12-31	-186.05%
2012-09-30	-31.91%
2012-06-30	-24.58%
2012-03-31	60.01%
2011-12-31	89.28%
2011-09-30	138.09%
2011-06-30	224.26%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	18.36%
2024-12-31	-23.55%
2023-12-31	-12.08%
2022-12-31	5.09%
2021-12-31	6.78%
2020-12-31	47.12%
2019-12-31	-472.83%
2018-12-31	-58.86%
2017-12-31	-45.81%
2016-12-31	-458.49%
2015-12-31	-533.28%
2014-12-31	-10.97%
2013-12-31	323.14%
2012-12-31	-186.05%
2011-12-31	89.28%
2010-12-31	-110.38%
2009-12-31	9.39%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)	United States	$11.879B	151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
Viatris Inc (VTRS)	United States	$20.008B	-0.00
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28